🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Betw...
Status
Unknown
Location
Lexicon Investigational Site
Start Date
2015-07
Trial ID
NCT02494609
Treatments Being Tested
The primary objective was: \- to assess the bioequivalence of a single dos...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2014-09
Trial ID
NCT02237508
Open-label, parallel, 2-arm, fixed-sequence study to investigate the effect...
Status
Completed
Location
QPS Missouri
Start Date
2020-10-24
Trial ID
NCT04606537
Treatments Being Tested
To compare the pharmacokinetic characteristics between HCP1201 tablet 750/1...
Status
Completed
Location
Samsung Medical Center
Start Date
2013-12
Trial ID
NCT02026817
Treatments Being Tested
The purpose of this study is to compare the pharmacokinetics of NVP-1205 an...
Status
Completed
Location
Kyungpook National Hospital
Start Date
2014-02
Trial ID
NCT02029625
Treatments Being Tested
\[Objectives\]Primary: To determine and compare the rate and extent of abso...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11-01
Trial ID
NCT04050098
This is a two-arm, open-label, single-sequence, multiple-dose, cross-over p...
Status
Completed
Location
H Plus Yangji Hospital
Start Date
2021-07-23
Trial ID
NCT05009368
Treatments Being Tested
A single 125 mg oral dose of the investigational compound PD-0332991 will b...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-04
Trial ID
NCT01821066
Treatments Being Tested
Primary endpoint of this study is to evaluate the pharmacokinetic character...
Status
Completed
Location
H+ Yangji Hospital
Start Date
2022-01-05
Trial ID
NCT05202405
Treatments Being Tested
The pharmacokinetics of 50 mg BIBR 1048 administered as two newly developed...
Status
Completed
Location
Multiple Locations
Start Date
2001-04
Trial ID
NCT02170805